ProPhase Labs, Inc. Public Float
ProPhase Labs, Inc. (PRPH) had Public Float of $15.16 million as of 2025-06-30, per its 10-K filed 2026-06-01.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-06-01
- 2025-06-30: Entity Public Float $15.16M.
- 2024-06-30: Entity Public Float $67.23M.
- 2023-06-30: Entity Public Float $100.24M.
- 2022-06-30: Entity Public Float $151.73M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $15.16M 10-K · filed 2026-06-01 |
| 2024-06-30 | $67.23M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $100.24M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $151.73M 10-K · filed 2023-03-29 |
| 2021-06-30 | $73.46M 10-K · filed 2022-03-31 |
| 2020-06-30 | $12.64M 10-K · filed 2021-03-31 |
| 2019-06-30 | $18.87M 10-K · filed 2020-03-26 |
| 2018-06-30 | $27.56M 10-K · filed 2019-03-26 |
| 2017-06-30 | $22.21M 10-K/A · filed 2018-08-20 |
| 2016-06-30 | $14.43M 10-K · filed 2017-02-24 |
| 2015-06-30 | $13.64M 10-K · filed 2016-03-29 |
| 2014-06-30 | $20.48M 10-K · filed 2015-03-27 |
| 2013-06-30 | $15.80M 10-K · filed 2014-03-27 |
| 2012-06-30 | $10.14M 10-K · filed 2013-03-28 |
| 2011-06-30 | $6.76M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |